Tailoring Structured Content Strategy in Pharma and Biotech

In pharmaceutical and biotech regulatory document development, your content strategy –  the business plan for how you create, manage, and deliver content  – significantly impacts your ability to innovate, comply with regulations, and ultimately, bring new medicines to market. It’s understandable to think that the pharma industry can take a uniform approach to content strategy. After all, a submission to a particular health authority contains approximately the same types of information in approximately the same order, regardless of sponsor. I say “approximately” because even with the guidance provided by the common technical document (CTD), there is noticeable variation from submission